Загрузка...
Should AFP (or any biomarkers) be used for HCC surveillance?
A) PURPOSE OF REVIEW: To address the controversy around the use of biomarkers for hepatocellular carcinoma (HCC) surveillance in individuals with cirrhosis or chronic hepatitis B who are at risk for development of liver cancer. B) RECENT FINDINGS: Recent studies suggest that surveillance for hepatoc...
Сохранить в:
| Опубликовано в: : | Curr Hepatol Rep |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5659201/ https://ncbi.nlm.nih.gov/pubmed/29085770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11901-017-0349-7 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|